Venus Medtech

Founded in 2009, Venus Medtech is located in Hangzhou, China and is committed to the development and industrialization of innovative medical devices in the field of structural heart disease. Venus Medtech has established comprehensive solutions for structural heart disease, with a complete product pipeline covering all four heart valves, namely TAVR, TPVR, TMVR and TTVR, as well as hypertrophic cardiomyopathy, hypertensive renal denervation (RDN) therapy and relevant accessory products.





VenusP-Valve™ System